CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Operating Leases, Rent Expense
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Operating Leases, Rent Expense of $30.40 million for the 12-month period ending 2018-12-29, per its 10-K filed 2019-02-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2019-02-13
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. operating leases, rent expense for fiscal 2018 was $30.40M, a 15.59% increase from fiscal 2017.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. operating leases, rent expense for fiscal 2017 was $26.30M, a 20.64% increase from fiscal 2016.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. operating leases, rent expense for fiscal 2016 was $21.80M, a 6.84% decline from fiscal 2015.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. operating leases, rent expense for fiscal 2015 was $23.40M, a 64.79% increase from fiscal 2014.
| Period end | Operating Leases, Rent Expense 12 month | Operating Leases, Rent Expense 12 month as first filed |
|---|---|---|
| 2018-12-29 | $30.40M 10-K · filed 2019-02-13 | |
| 2017-12-30 | $26.30M 10-K · filed 2019-02-13 | |
| 2016-12-31 | $21.80M 10-K · filed 2019-02-13 | |
| 2015-12-26 | $23.40M 10-K · filed 2018-02-13 | |
| 2014-12-27 | $14.20M 10-K · filed 2017-02-14 | $14.22M 10-K · filed 2015-02-17 |
| 2013-12-28 | $16.70M 10-K · filed 2016-02-12 | $16.73M 10-K · filed 2014-02-25 |
| 2012-12-29 | $18.20M 10-K · filed 2015-02-17 | $18.25M 10-K · filed 2013-02-27 |
| 2011-12-31 | $18.78M 10-K · filed 2014-02-25 | |
| 2010-12-25 | $22.64M 10-K · filed 2013-02-27 | |
| 2009-12-26 | $19.95M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |